Trials / Completed
CompletedNCT04667936
Evaluation of Sedation in COVID-19 ARDS
Evaluation of Impaired Sedation in Patients With Moderate to Severe COVID-19 ARDS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 114 (actual)
- Sponsor
- Goethe University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study focuses on the evaluation of various factors repeatedly discussed in relation to the impaired sedation of intubated ventilated COVID-19 patients. The sedation response of \>100 moderately to severely affected COVID-19 ARDS was evaluated. The sedation level was measured at the bedside using the Richmond Agitation and Sedation Scale and ventilator synchrony. The evaluation was performed according to the static evaluation plan with respect to age, storage therapy and organ failure.
Conditions
- Prone Position
- Severe Acute Respiratory Syndrome Coronavirus 2
- Hypnotics and Sedatives
- Pulmonary Ventilation
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Treatment group | None, solely treatment documentation |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2020-12-15
- Completion
- 2021-04-01
- First posted
- 2020-12-16
- Last updated
- 2021-07-01
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04667936. Inclusion in this directory is not an endorsement.